(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

UPLYFTA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

UPLYFTA

ST13

US500000079263128

Class

10

Filing

79263128

Registration

5947026

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

08/11/2026

Trademark type

Word

Nice classes

10

Filing date

05/15/2019

Registration date

12/31/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/17/2026

Last transaction

08/11/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

POLZER, NATALIE M

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Novartis AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Drug delivery devicesinjection devices for pharmaceuticalsinjection devices for administering drugs

Publications

History of USPTO decisions and trademark events.

32 publications found

C71T

CANCELLED SECTION 71

07/17/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/31/2024

FINP

FINAL DECISION TRANSACTION PROCESSED BY IB

10/11/2020

GPNX

NOTIFICATION PROCESSED BY IB

07/03/2020

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

05/15/2020

IRRH

IRREGULARITY FROM IB EXAMINED BY MPU

05/15/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

05/15/2020

IRFI

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

04/28/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/16/2020

FIMP

FINAL DISPOSITION PROCESSED

04/16/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/31/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

12/31/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2019

PUBO

PUBLISHED FOR OPPOSITION

10/15/2019

GPNX

NOTIFICATION PROCESSED BY IB

10/12/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/25/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/25/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2019

ALIE

ASSIGNED TO LIE

09/12/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/10/2019

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

08/21/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/20/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/08/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/26/2019

CNRT

NON-FINAL ACTION WRITTEN

07/25/2019

DOCK

ASSIGNED TO EXAMINER

07/25/2019

MAFR

APPLICATION FILING RECEIPT MAILED

07/23/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/19/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/18/2019

Continuous trademark protection

Get notified about every new filing that threatens UPLYFTA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.